Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy
Authors:
Open Access
- 1 January 2020
- journal article
- research article
- Published by Ivyspring International Publisher in Theranostics
- Vol. 10 (26) , 11921-11937
Abstract
Generating oxidative stress is a critical mechanism by which host cells defend against infection by pathogenic microorganisms. Radiation resistance is a critical problem in radiotherapy against cancer. Epstein-Barr virus (EBV) is a cancer-causing virus and its reactivation plays an important role in the development of EBV-related tumors. This study aimed to explore the inner relationship and regulatory mechanism among oxidative stress, EBV reactivation, and radioresistance and to identify new molecular subtyping models and treatment strategies to improve the therapeutic effects of radiotherapy.Keywords
This publication has 63 references indexed in Scilit:
- Down-Regulation of EBV-LMP1 Radio-Sensitizes Nasal Pharyngeal Carcinoma Cells via NF-κB Regulated ATM ExpressionPLOS ONE, 2011
- Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overviewJournal of Translational Medicine, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Regulation of cancer cell metabolismNature Reviews Cancer, 2011
- Accumulation of oxidized proteins in Herpesvirus infected cellsFree Radical Biology and Medicine, 2010
- Epstein–Barr Virus DNase (BGLF5) induces genomic instability in human epithelial cellsNucleic Acids Research, 2009
- The Epstein–Barr virus Bcl-2 homolog, BHRF1, blocks apoptosis by binding to a limited amount of BimProceedings of the National Academy of Sciences, 2009
- The Epstein–Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen speciesProceedings of the National Academy of Sciences, 2009
- Oxidative Innate Immune Defenses by Nox/Duox Family NADPH Oxidases2008
- Host shutoff during productive Epstein–Barr virus infection is mediated by BGLF5 and may contribute to immune evasionProceedings of the National Academy of Sciences, 2007